Provide strategic and technical leadership for CMC activities, overseeing technology transfer, scale-up, and cGMP manufacturing for small molecule drug development.
Manage contract manufacturing organizations and author regulatory submission sections to ensure alignment and timely achievement of program milestones.
Collaborate cross-functionally with Quality, Regulatory Affairs, and Supply Chain to support clinical and commercial goals from Phase I through commercialization.
Travere Therapeutics is a biopharmaceutical company dedicated to identifying, developing, and delivering life-changing therapies for people living with rare disease. The company is a dedicated team focused on meeting the unique needs of rare patients, fostering a collaborative, diverse, and fast-paced environment centered on patients, courage, community, and collaboration.
BridgeBio is a biopharmaceutical company founded to discover, create, test and deliver transformative medicines for genetic diseases and cancers with clear genetic drivers. Founded in 2015, the company has a portfolio of 20+ drug development programs and offices in the US, Canada, and Switzerland, focusing on scientific excellence and rapid execution.
Lead the Manufacturing and Supply Chain function, partnering with external providers and internalizing capabilities to advance the pipeline.
Evaluate, source, and manage contract manufacturers and supply organizations for autologous and allogeneic CAR T therapies globally.
Manage clinical supply, materials management, and strategic sourcing while ensuring network readiness for pivotal studies and commercial launch.
Kyverna is a cell therapy company engineering and developing curative living medicines for inflammatory and autoimmune diseases. The company is building on oncology CAR T technology and values intellectual humility, elevating each other, and staying true to why.
Lead integrated asset strategy across the full product lifecycle, from research through commercialization.
Drive strategic planning for emerging therapeutic platform technologies and evaluate portfolio opportunities.
Partner cross-functionally with Research, Clinical, Regulatory, and Commercial teams to ensure alignment and execution.
Kyverna Therapeutics is a clinical-stage biopharmaceutical company developing cell therapies for autoimmune diseases. Guided by core values, the company is committed to transforming treatment for autoimmune disease.